Cargando…
Chondroitin Sulfate Inhibits Monocyte Chemoattractant Protein-1 Release From 3T3-L1 Adipocytes: A New Treatment Opportunity for Obesity-Related Inflammation?
Monocyte chemoattractant protein-1 (MCP-1) overproduction from inflamed adipose tissue is a major contributor to obesity-related metabolic syndromes. 3T3-L1 embryonic fibroblasts were cultured and differentiated into adipocytes using an established protocol. Adipocytes were treated with lipopolysacc...
Autores principales: | Stabler, Thomas V, Montell, Eulàlia, Vergés, Josep, Huebner, Janet L, Kraus, Virginia Byers |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574472/ https://www.ncbi.nlm.nih.gov/pubmed/28890654 http://dx.doi.org/10.1177/1177271917726964 |
Ejemplares similares
-
Monosodium urate crystal induced macrophage inflammation is attenuated by chondroitin sulphate: pre-clinical model for gout prophylaxis?
por: Orlowsky, Eric W, et al.
Publicado: (2014) -
Discrepancies in Composition and Biological Effects of Different Formulations of Chondroitin Sulfate
por: Martel-Pelletier, Johanne, et al.
Publicado: (2015) -
Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate
por: Lambert, Cécile, et al.
Publicado: (2012) -
Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes
por: Calamia, Valentina, et al.
Publicado: (2010) -
Immunomodulatory and anti-inflammatory effects of chondroitin sulphate
por: du Souich, Patrick, et al.
Publicado: (2009)